Registration Filing
Logotype for Jones Soda Co

Jones Soda (JSDA) Registration Filing summary

Event summary combining transcript, slides, and related documents.

Logotype for Jones Soda Co

Registration Filing summary

29 Nov, 2025

Company overview and business model

  • Develops, markets, and distributes premium beverages in the US, Canada, and select international markets through independent distributors and direct retail channels.

  • Product lines include craft sodas (Jones Soda), modern sodas (Pop Jones, Fiesta Jones), and alternative adult beverages (Mary Jones, Spiked Jones).

  • Outsources manufacturing to third-party contract manufacturers and leverages online sales and brand licensing.

  • Recently sold THC-infused cannabis subsidiaries for $3M, retaining a license agreement for hemp-derived Delta-9 THC products.

  • Focuses on expanding product lines, distribution channels, and brand engagement through consumer interaction and innovative marketing.

Financial performance and metrics

  • 2024 net revenue: $19.2M, up 14.9% from 2023, driven by higher beverage sales and 9% growth in cannabis business.

  • Gross profit for 2024: $4.1M, down 16.1% due to $1.2M inventory impairment; gross margin fell to 21.3% from 29.1%.

  • 2024 net loss: $9.9M, up from $4.9M in 2023, mainly due to inventory impairment, increased marketing, and legal costs.

  • Q1 2025 net loss: $0.9M, improved from $1.2M in Q1 2024, with reduced marketing and G&A expenses.

  • As of March 31, 2025: $0.7M cash, $1.3M working capital, and $93.8M accumulated deficit.

Use of proceeds and capital allocation

  • Net proceeds will be used for working capital and general corporate purposes.

  • May allocate funds to in-license, acquire, or invest in complementary businesses or products, with no current commitments.

  • Management has broad discretion over the use of proceeds.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more